Intrexon | XON - Заемный капитал





Заемный капитал Изменить Дата
Agenus USD 153.98M 15.68M 2026-03
Alaunos Therapeutics USD 4.47M 5.85M 2022-06
Amgen USD 51.86B 27M 2026-06
Arrowhead Research USD 824.07M 401.34M 2026-06
AstraZeneca USD 26.01B 46M 2026-06
Bristol-Myers Squibb USD 42.09B 59M 2026-06
Gilead Sciences USD 20.86B 1.27B 2026-03
GlaxoSmithKline GBP 13.95B 65M 2026-06
Heron Therapeutics USD 140.64M 975K 2025-12
Incyte USD 28.42M 994K 2026-06
Intrexon USD 0 198.67M 2024-06
Karyopharm Therapeutics USD 264.49M 13.73M 2026-03
Ligand Pharmaceuticals USD 446.9M 704K 2026-03
MacroGenics USD 68.71M 1.29M 2026-03
MannKind USD 545.13M 2.93M 2026-06
Merck USD 51.08B 4.41B 2026-06
Novartis USD 37.49B 42M 2026-06
Rigel Pharmaceuticals USD 0 0 2024-09
Roche Holding CHF 25.22B 2.21B 2026-06
Sangamo BioSciences USD 0 0 2022-06
Thermo Fisher Scientific USD 39.18B 890M 2026-06
Veracyte USD 0 0 2025-03
Xencor USD 77.54M 4.59M 2026-06